1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration
under Section 12(g) of the Securities Exchange Act of 1934
or Suspension of Duty to File Reports Under Sections 13
and 15(d) of the Securities Exchange Act of 1934
Commission File No. 0-18366
PHARMACY MANAGEMENT SERVICES, INC.
(Exact name of registrant as specified in its charter)
3611 Queen Palm Drive
Tampa, Florida 33619
(Address, including zip code and telephone number, including
area code, of registrant's principal executive offices)
Common Stock, $.01 par value
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty
to file reports under section 13(a) or 15(d) remains)
Place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) /x/ Rule 12h-3(b)(1)(ii) / /
Rule 12g-4(a)(1)(ii) / / Rule 12h-3(b)(2)(i) / /
Rule 12g-4(a)(2)(i) / / Rule 12h-3(b)(2)(ii) / /
Rule 12g-4(a)(2)(ii) / / Rule 15d-6
Rule 12h-3(b)(1)(i) / /
Approximate number of holders of record as of the certification or
notice date: None
Pursuant to the requirements of the Securities Exchange Act of 1934,
Pharmacy Management Services, Inc. has caused this certification/notice to be
signed on its behalf by the undersigned duly authorized person.
Dated: June 27, 1995 PHARMACY MANAGEMENT SERVICES, INC.
By: /s/ David L. Redmond
-------------------------------
David L. Redmond, Secretary,
Senior Vice President, and
Chief Financial Officer